Patent Assignment
Reel/Frame 072331/0001
Security Interest
Recorded: 2025-08-01
Pages: 31
Assignor
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Executed: 2025-08-01
Assignee
COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
1505 ENERGY PARK DRIVE, ST. PAUL, MINNESOTA, 55108
Covered Properties
(214)
Method and Apparatus for the Administration of Co
System and Method of Administering a Pharmaceutical Gas to a Patient
Method and apparatus for generating nitric oxide for medical use
Reduced Dose Intravenous Acetaminophen
System and Method of Administering a Pharmaceutical Gas to a Patient
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Children in Need of Treatment with Inhaled Nitric Oxide
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Term or Near-Term Neonates in Need of Treatment with Inhaled Nitric Oxide
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Dosing Regimens and Methods of Treatment Using Carbon Monoxide
Powder Delivery Device
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Acth Prophylactic Treatment of Renal Disorders
Patent:
8,796,416 →
Application:
13/281,175 →
System And Method Of Administering A Pharmaceutical Gas To A Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
Treatment of Tissue Adhesion
Systems And Methods Of Administering A Pharmaceutical Gas to A Patient
Breathing Apparatus Detection and Purging
Gas Delivery Device and System
Gas Delivery Device and System
Dry Powder Fibrin Sealant
System And Method Of Administering A Pharmaceutical Gas To A Patient
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Apparatus and Method for Monitoring Nitric Oxide Delivery
Nitric Oxide Delivery Device
Methods of Distributing a Pharmaceutical Product Comprising Nitric Oxide Gas for Inhalation
Methods for Treating Patients Who Are Candidates for Inhaled Nitric Oxide Treatment
System and Method of Administering a Pharmaceutical Gas to a Patient
Apparatus and Method for Monitoring Nitric Oxide Delivery
Methods Of Administering High Concentrations Of Nitric Oxide
System And Method Of Administering A Pharmaceutical Gas To A Patient
System and Method of Administering a Pharmaceutical Gas to a Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
Clinical Decision Support System and Methods
Nitric Oxide Delivery Device
Gas Delivery Device and System
Gas Delivery Device and System
Administration And Monitoring Of Nitric Oxide In Ex Vivo Fluids
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Therapeutic Gas Delivery Device with Pulsed and Continuous Flow Control
Acth for Treatment of Acute Respiratory Distress Syndrome
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Method And Apparatus For Generating Nitric Oxide For Medical Use
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Acth Prophylactic Treatment of Renal Disorders
Nitric Oxide Delivery Device
Breathing Apparatus Detection and Purging
Methods of Administering Nitric Oxide to Arterial or Arterialized Blood
Systems and Methods of Administering a Pharmaceutical Gas to a Patient
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Systems And Methods For Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed To Nitric Oxide
Gas Delivery Device And System
Gas Delivery Device And System For Use In Magnetic Resonance Imaging
Systems And Method For Delivery Of Therapeutic Gas To Patients In Need Thereof Using Enhanced Breathing Circuit Gas (BCG) Flow Measurement
Systems And Method For Delivery Of Therapeutic Gas To Patients In Need Thereof Using Enhanced Breathing Circuit Gas (BCG) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Systems And Methods For Intelligent Gas Source Management
Enhanced Performance Verification Port For Therapeutic Gas Delivery
Systems and Methods for Delivery of Therapeutic Gas
Systems And Methods For Indicating Lifetime Of An NO2-to-NO Reactor Cartridge Used To Deliver NO For Inhalation Therapy To A Patient
Systems And Methods For Manufacturing And Safety Of An NO2-to-NO Reactor Cartridge Used To Deliver NO For Inhalation Therapy To A Patient
Patent:
10,384,031 →
Application:
14/744,298 →
Breathing Apparatus Detection and Purging
Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness
Method of Treating Patients with Hepatorenal Syndrome Type 1
Gas Delivery Device and System
Method and Apparatus for Generating Nitric Oxide for Medical Use
Systems And Methods for Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed to Nitric Oxide
Administration And Monitoring Of Nitric Oxide In Ex Vivo Fluids
System And Method Of Administering A Pharmaceutical Gas To A Patient
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Reduced Dose Intravenous Acetaminophen
Nitric Oxide Delivery Device
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Device And Method For Diffusing High Concentration NO With Inhalation Therapy Gas
Systems And Methods for Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed to Nitric Oxide
Method of Identifying and Treating Premature Infants at Risk for BPD
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Acth Prophylactic Treatment of Renal Disorders
Biodegradable Extravascular Stent
Breathing Apparatus Detection and Purging
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Use And Monitoring Of Inhaled Nitric Oxide With Left Ventricular Assist Devices
Compensating for Disruptions in Breathing Gas Flow Measurement
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Reduced Dose Intravenous Acetaminophen
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Apparatus and Method for Monitoring Nitric Oxide Delivery
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Methods of Reducing the Risk of Mortality Associated With a Medical Treatment
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Reduced Dose Intravenous Acetaminophen
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
System And Method Of Administering A Pharmaceutical Gas To A Patient
Systems and Methods for Intelligent Gas Source Management and/or Systems and Methods for Delivery of Therapeutic Gas and/or Enhanced Performance Verification for Therapeutic Gas Delivery
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Gas Delivery Device and System for Use in Magnetic Resonance Imaging
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Devices and Methods for Monitoring Oxygenation Uring Treatment with Delivery of Nitric Oxide
Application:
16/365,263 →
Publication:
US 2019/0216377
Methods of Administering Inhaled Nitric Oxide Gas
Systems and Methods for Manufacturing and Safety of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Apparatus and Method for Monitoring Nitric Oxide Delivery
Compensating for Disruptions in Breathing Gas Flow Measurement
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Clinical Decision Support System and Methods
Systems and Methods for Indicating Lifetime of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Systems and Methods for Delivery of Therapeutic Gas
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Methods Of Administering High Concentrations Of Nitric Oxide
Method of Identifying and Treating Premature Infants at Risk for Bpd
Intelligent Gas Source Management
Systems and Methods for Intelligent Gas Source Management
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Methods to Increase Functional Capacity and Quality of Life in Bronchietasis Patients with Nontuberculous Mycobacteria
Application:
16/875,000 →
Publication:
US 2020/0360648
Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension
Application:
16/961,886 →
Publication:
US 2020/0360425
Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness
Application:
17/007,603 →
Publication:
US 2020/0398019
Method and Apparatus for Pulsatile Delivery of Nitric Oxide
Application:
17/055,365 →
Publication:
US 2021/0220586
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/104,864 →
Device And Method For Diffusing High Concentration NO With Inhalation Therapy Gas
Application:
17/151,410 →
Publication:
US 2021/0138178
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Application:
17/175,779 →
Publication:
US 2021/0260327
Methods of Modulating Pericytes
Patent:
11,752,199 →
Application:
17/185,586 →
Gas Sensor Module
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/340,765 →
Publication:
US 2021/0290725
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
Methods of Modulating Corticosteroid Response
Application:
17/362,497 →
Publication:
US 2021/0322520
USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONS
Application:
17/420,406 →
Publication:
US 2022/0080147
Methods of Promoting Remyelination
Application:
17/420,622 →
Publication:
US 2022/0111012
Combination Drug Therapies of Pde-5 Inhibitors and Inhaled Nitric Oxide
Application:
17/421,803 →
Publication:
US 2022/0096535
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/587,442 →
Publication:
US 2022/0143132
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Intelligent Gas Source Management
Compensating for Disruptions in Breathing Gas Flow Measurement
IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
Application:
17/796,451 →
Publication:
US 2023/0067942
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
Application:
17/917,209 →
Publication:
US 2023/0158064
Method of Identifying and Treating Premature Infants at Risk for Bpd
Methods and Compositions for Improving Kidney Function in Patients with Hepatorenal Syndrome
Application:
17/976,502 →
Publication:
US 2023/0108970
Methods and Compositions for Improving Kidney Function in Patients with Hepatorenal Syndrome
Application:
17/976,603 →
Publication:
US 2023/0054888
Methods and Compositions for Improving Kidney Function in Patients with Hepatorenal Syndrome
Application:
17/976,606 →
Publication:
US 2023/0126586
Systems and Methods for Delivery of Therapeutic Gas
Method for Pulsatile Delivery of a Gaseous Drug
Application:
18/000,188 →
Publication:
US 2023/0201497
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Systems and Methods for Manufacturing and Safety of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Systems and Methods for Intelligent Gas Source Management
Application:
18/109,506 →
Publication:
US 2023/0226291
Systems and Methods for Delivery of Therapeutic Gas
Application:
18/109,510 →
Publication:
US 2023/0270960
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Application:
18/117,917 →
Publication:
US 2023/0201495
Methods Of Administering High Concentrations Of Nitric Oxide
Application:
18/136,522 →
Publication:
US 2023/0256190
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Methods to Improve Organ Viability
Compositions for Improving Kidney Function in Patients with Hepatorenal Syndrome
Application:
18/416,231 →
Publication:
US 2024/0307483
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
18/431,587 →
Publication:
US 2024/0238364
Therapeutic Gas Delivery System and Operation
Application:
18/441,180 →
Publication:
US 2024/0274283
Filter Assembly for a Therapeutic Gas Delivery Device
Application:
18/441,201 →
Publication:
US 2024/0269608
Sample Gas Filter for a Therapeutic Gas Delivery Device
Application:
18/441,216 →
Publication:
US 2024/0269418
Pre-Filled Manual Injector Apparatus
Application:
18/480,264 →
Publication:
US 2024/0042135
Gas Sensor Module with Enhanced Flow
Application:
18/630,745 →
Publication:
US 2024/0342411
Methods of Reducing the Risk of Mortality Associated With a Medical Treatment
Application:
18/639,099 →
Publication:
US 2024/0390634
Use of Inhaled Nitric Oxide (Ino) for Treating Patients with Pulmonary Hypertension Associated with Sarcoidosis (Ph-Sarc)
Application:
18/726,314 →
Publication:
US 2025/0302869
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Application:
18/732,187 →
Publication:
US 2024/0316300
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
18/783,546 →
Publication:
US 2024/0366710
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
18/783,556 →
Publication:
US 2024/0374674
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
18/783,572 →
Publication:
US 2024/0374675
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
18/783,777 →
Publication:
US 2024/0374676
Apparatus and Method for Monitoring Nitric Oxide Delivery
Application:
18/802,041 →
Publication:
US 2024/0399098
Systems and Methods for Delivery of Therapeutic Gas
Application:
18/985,280 →
Publication:
US 2025/0114544
Methods to Improve Organ Viability
Application:
19/098,522 →
Publication:
US 2025/0228235
Pre-Filled Manual Injector Apparatus
Application:
19/169,718 →
Publication:
US 2025/0255937
Gas Sensor Module
Application:
19/196,102 →
Publication:
US 2025/0258066
Compositions for Improving Kidney Function in Patients with Hepatorenal Syndrome
Application:
19/213,363 →
Publication:
US 2025/0276033
Preparation of Sufentanil Citrate and Sufentanil Base
Application:
19/246,191 →
Publication:
US 2025/0368630
Medical Powder Delivery Instrument
Patent:
683,851 →
Application:
29/394,931 →
Therapeutic Gas Delivery Device
Patent:
701,963 →
Application:
29/455,842 →
Therapeutic Gas Delivery Device
Patent:
729,936 →
Application:
29/464,499 →
Therapeutic Gas Delivery Device
Patent:
730,525 →
Application:
29/467,025 →
Therapeutic Gas Delivery Device
Patent:
729,937 →
Application:
29/467,028 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
776,278 →
Application:
29/544,067 →
MRI Compatible Therapeutic Gas Delivery Cart
Patent:
776,279 →
Application:
29/544,072 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
797,935 →
Application:
29/578,294 →
MRI Compatible Therapeutic Gas Delivery Cart
Patent:
807,510 →
Application:
29/578,295 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
823,472 →
Application:
29/614,133 →
Gas Cylinder
Patent:
1,073,017 →
Application:
29/884,628 →
Therapeutic Gas Delivery Device
Patent:
1,108,635 →
Application:
29/884,630 →
Therapeutic Gas Delivery Cart
Patent:
1,064,285 →
Application:
29/884,631 →
Injector Module
Patent:
1,092,732 →
Application:
29/884,632 →
Therapeutic Gas Cylinder Bay
Patent:
1,092,742 →
Application:
29/884,634 →
Display Screen or Portion Thereof with Graphical User Interface
Patent:
1,069,817 →
Application:
29/884,635 →
Display Screen or Portion Thereof with Graphical User Interface
Patent:
1,061,594 →
Application:
29/884,636 →
Display Screen or Portion Thereof with Graphical User Interface
Patent:
1,060,405 →
Application:
29/884,637 →
Display Screen or Portion Thereof with Graphical User Interface
Patent:
1,087,129 →
Application:
29/884,639 →
Therapeutic Gas Delivery Cart
Patent:
1,086,469 →
Application:
29/969,823 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 2, 2017
From: ACTHAR IP
To: MALLINCKRODT ARD IP LIMITED
Reel/Frame 041444/0074 →
Assignment of Assignor's Interest
Mar 2, 2017
From: QUESTCOR PHARMACEUTICALS, INC.
To: ACTHAR IP
Reel/Frame 041443/0923 →
Change of Name
Nov 2, 2018
From: MALLINCKRODT IP
To: MALLINCKRODT IP UNLIMITED COMPANY
Reel/Frame 047404/0945 →
Nunc Pro Tunc Assignment
Nov 2, 2018
From: MALLINCKRODT IP UNLIMITED COMPANY
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 047394/0214 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT ARD IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049821/0425 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 043596, Frame 0259
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0324 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Patent Security Interests Recorded at Reel 049821, Frame 0425
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0176 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 035454, Frame 0768
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0035 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →
Assignment of Assignor's Interest
Aug 16, 2025
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072040/0424 →
Change of Name
Aug 16, 2025
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 072477/0834 →
Security Interest
Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →